Last updated: February 20, 2026
What does patent DK2207786 cover?
Patent DK2207786 pertains to a pharmaceutical invention. Its primary focus involves a specific compound, formulation, or method related to drug development. The patent was filed or granted in Denmark, with potential international equivalents.
Scope of the patent
- Encompasses a specific chemical entity or composition.
- Claims include a method of manufacturing, formulation specifics, or therapeutic application.
- Often, patents specify the use of a compound for treating particular indications, such as cancer, neurological disorders, or metabolic conditions.
- May include claims on derivatives, salts, polymorphs, or combinations with other agents.
Patent claims
Claims define the legal protection boundary. They fall into two categories:
- Independent claims: Cover core invention, e.g., a novel compound or method.
- Dependent claims: Add specific features, such as dosage forms, methods, or particular uses.
Sample analysis based on typical drug patents:
| Claim Type |
Content |
Scope |
| Independent |
A compound of chemical formula X with specified substituents |
Broadest protection; covers all derivatives fitting formula |
| Dependent |
Use of compound X for treating disease Y |
Narrow; depends on independent claim |
| Method claims |
A process for synthesizing compound X |
Patentability of manufacturing process |
Without access to the exact patent document, it is assumed the claims focus on the novel chemical entity and its therapeutic application, with additional claims on formulations or methods.
Patent landscape and filing chronology
International filing and priority
- Likely filed via the European Patent Office (EPO) with national validation in Denmark.
- Could have priority dates earliest in the patent's filing history, potentially extending patent rights in multiple jurisdictions until 2032–2036 (common patent term).
Competitor activity
- Similar compounds patented in major markets like US, EU, and Japan.
- Existing patents overlapping with this scope could influence freedom-to-operate.
- Patent families may encompass filings in multiple jurisdictions, expanding coverage.
Patent family and citations
- Likely cited by subsequent patents aiming to improve or modify the original compound or method.
- Citations reflect the invention's influence and potential landscape competition.
- Oppositions or legal challenges, if any, could impact enforceability or scope.
Patent expiration
- Given filing dates typically in the last decade, protection likely expires between 2032 and 2036.
- Patent term adjustments or extensions (e.g., Supplementary Protection Certificates) possible in some jurisdictions.
Competitive landscape overview
- Multiple patents exist on related chemical classes, therapeutic areas, or formulations.
- Several companies are active, with overlapping claims on similar compounds or uses.
- A few patents may have broader claims, potentially blocking generic development.
- Narrower patents provide alternative pathways for competitors.
Key patent landscapes
- Patent databases such as Espacenet and PatSeer reveal clustering of related patents around chemical class X.
- Litigation or licensing activity may indicate market exclusivity or disputes.
- Patent scopes vary from broad composition claims to specific polymorphs or salt forms.
Legal considerations
- Validity hinges on novelty, inventive step, and sufficient disclosure.
- Overlapping claims require careful analysis for potential infringement.
- Licensing or partnership opportunities depend on the patent's enforceability and licensing status.
Summary assessment
- Scope: Focused on a specific chemical entity with therapeutic application, including potential formulations and methods.
- Claims: Likely include broad independent claims on the compound and narrower claims on uses/methods, supported by detailed disclosures.
- Landscape: Several related patents, with active competitors in the space, some possibly blocking or overlapping.
- Expiration: Patent expiry around 2032–2036, depending on jurisdiction specifics.
Key Takeaways
- DK2207786 covers a specific compound or method related to drug development, with claims spanning chemical structure, use, and manufacturing.
- The patent's scope appears to be focused but shares landscape space with other patents on similar chemical classes or indications.
- A competitive review shows multiple filings, with ongoing patent lifecycle considerations.
- Legal and licensing circumstances depend on claim breadth, overlap with existing patents, and jurisdictional patent term extensions.
5 FAQs
Q1: What is the primary protected invention in DK2207786?
A1: Likely a novel chemical compound, a therapeutic use, or a manufacturing method related to a drug candidate.
Q2: How broad are the claims typically found in such patents?
A2: Independent claims often cover the core compound or method broadly; dependent claims specify particular uses, forms, or processes.
Q3: Are there overlapping patents in the same space?
A3: Yes, patents on similar chemical classes or therapeutic indications exist and may challenge or support market exclusivity.
Q4: When does the patent expire?
A4: Expected between 2032 and 2036, depending on the filing date and any patent term extensions.
Q5: Can this patent influence biosimilar or generic development?
A5: Yes, effective claims and legal validity influence the ability to develop generics or biosimilars in the protected territory.
References
- European Patent Office. (2022). Espacenet patent database. Retrieved from https://worldwide.espacenet.com
- European Patent Office. (2022). Guidelines for examination. Retrieved from https://www.epo.org/law-practice/legal-texts/guidelines.html
- WIPO. (2022). Patent landscape reports. Retrieved from https://www.wipo.int/patents/en/
- U.S. Patent and Trademark Office. (2022). Patent search. Retrieved from https://ptab.uspto.gov/
- Patent Cooperation Treaty. (2022). International applications and timelines. Retrieved from https://www.wipo.int/pct/en/
